MeSH Review:
Basal Ganglia
- Manganese and chronic hepatic encephalopathy. Krieger, D., Krieger, S., Jansen, O., Gass, P., Theilmann, L., Lichtnecker, H. Lancet (1995)
- Evidence for a cerebral effect of the hepatitis C virus. Forton, D.M., Allsop, J.M., Main, J., Foster, G.R., Thomas, H.C., Taylor-Robinson, S.D. Lancet (2001)
- Dopamine-dependent synaptic plasticity in striatum during in vivo development. Tang, K., Low, M.J., Grandy, D.K., Lovinger, D.M. Proc. Natl. Acad. Sci. U.S.A. (2001)
- Neuronal death enhanced by N-methyl-D-aspartate antagonists. Ikonomidou, C., Stefovska, V., Turski, L. Proc. Natl. Acad. Sci. U.S.A. (2000)
- The neural mechanisms underlying levodopa-induced dyskinesia in Parkinson's disease. Brotchie, J.M. Ann. Neurol. (2000)
- D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects. Walters, J.R., Bergstrom, D.A., Carlson, J.H., Chase, T.N., Braun, A.R. Science (1987)
- Viral gene delivery selectively restores feeding and prevents lethality of dopamine-deficient mice. Szczypka, M.S., Mandel, R.J., Donahue, B.A., Snyder, R.O., Leff, S.E., Palmiter, R.D. Neuron (1999)
- Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. Goodman, W.K., Price, L.H., Delgado, P.L., Palumbo, J., Krystal, J.H., Nagy, L.M., Rasmussen, S.A., Heninger, G.R., Charney, D.S. Arch. Gen. Psychiatry (1990)
- Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder. Castellanos, F.X., Giedd, J.N., Berquin, P.C., Walter, J.M., Sharp, W., Tran, T., Vaituzis, A.C., Blumenthal, J.D., Nelson, J., Bastain, T.M., Zijdenbos, A., Evans, A.C., Rapoport, J.L. Arch. Gen. Psychiatry (2001)
- Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Kalanithi, P.S., Zheng, W., Kataoka, Y., DiFiglia, M., Grantz, H., Saper, C.B., Schwartz, M.L., Leckman, J.F., Vaccarino, F.M. Proc. Natl. Acad. Sci. U.S.A. (2005)
- Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Nasir, J., Floresco, S.B., O'Kusky, J.R., Diewert, V.M., Richman, J.M., Zeisler, J., Borowski, A., Marth, J.D., Phillips, A.G., Hayden, M.R. Cell (1995)
- Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Strong, T.V., Tagle, D.A., Valdes, J.M., Elmer, L.W., Boehm, K., Swaroop, M., Kaatz, K.W., Collins, F.S., Albin, R.L. Nat. Genet. (1993)
- Brain neurotransmitters in dystonia musculorum deformans. Hornykiewicz, O., Kish, S.J., Becker, L.E., Farley, I., Shannak, K. N. Engl. J. Med. (1986)
- Evidence for striatal dopamine release during a video game. Koepp, M.J., Gunn, R.N., Lawrence, A.D., Cunningham, V.J., Dagher, A., Jones, T., Brooks, D.J., Bench, C.J., Grasby, P.M. Nature (1998)
- Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Picciotto, M.R., Zoli, M., Rimondini, R., Léna, C., Marubio, L.M., Pich, E.M., Fuxe, K., Changeux, J.P. Nature (1998)
- Striatal dopamine depletion, dopamine receptor stimulation, and GABA metabolism: implications for the therapy of Parkinson's disease. Bennett, J.P. Ann. Neurol. (1986)
- Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. Geissler, A., Lock, G., Fründ, R., Held, P., Hollerbach, S., Andus, T., Schölmerich, J., Feuerbach, S., Holstege, A. Hepatology (1997)
- Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Hilker, R., Klein, C., Ghaemi, M., Kis, B., Strotmann, T., Ozelius, L.J., Lenz, O., Vieregge, P., Herholz, K., Heiss, W.D., Pramstaller, P.P. Ann. Neurol. (2001)
- Alpha-tocopherol levels in brain are not altered in Parkinson's disease. Dexter, D.T., Ward, R.J., Wells, F.R., Daniel, S.E., Lees, A.J., Peters, T.J., Jenner, P., Marsden, C.D. Ann. Neurol. (1992)
- Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Sian, J., Dexter, D.T., Lees, A.J., Daniel, S., Agid, Y., Javoy-Agid, F., Jenner, P., Marsden, C.D. Ann. Neurol. (1994)
- Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice. Steiner, H., Bonner, T.I., Zimmer, A.M., Kitai, S.T., Zimmer, A. Proc. Natl. Acad. Sci. U.S.A. (1999)
- Region-dependent dynamics of cAMP response element-binding protein phosphorylation in the basal ganglia. Liu, F.C., Graybiel, A.M. Proc. Natl. Acad. Sci. U.S.A. (1998)
- Regulation of rat cortex function by D1 dopamine receptors in the striatum. Steiner, H., Kitai, S.T. J. Neurosci. (2000)
- Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions. Murer, M.G., Dziewczapolski, G., Menalled, L.B., García, M.C., Agid, Y., Gershanik, O., Raisman-Vozari, R. Ann. Neurol. (1998)
- Phosphoinositide second messenger system is enriched in striosomes: immunohistochemical demonstration of inositol 1,4,5-trisphosphate receptors and phospholipase C beta and gamma in primate basal ganglia. Fotuhi, M., Dawson, T.M., Sharp, A.H., Martin, L.J., Graybiel, A.M., Snyder, S.H. J. Neurosci. (1993)
- Neuropeptide Y distribution in human brain. Adrian, T.E., Allen, J.M., Bloom, S.R., Ghatei, M.A., Rossor, M.N., Roberts, G.W., Crow, T.J., Tatemoto, K., Polak, J.M. Nature (1983)
- Expression of human HPRT in the central nervous system of transgenic mice. Stout, J.T., Chen, H.Y., Brennand, J., Caskey, C.T., Brinster, R.L. Nature (1985)
- Brain dopamine and serotonin receptor sites revealed by digital subtraction autoradiography. Altar, C.A., O'Neil, S., Walter, R.J., Marshall, J.F. Science (1985)
- Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis. Graybiel, A.M., Canales, J.J., Capper-Loup, C. Trends Neurosci. (2000)
- Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family. Ernfors, P., Wetmore, C., Olson, L., Persson, H. Neuron (1990)
- Dopamine visualized in the basal ganglia of living man. Garnett, E.S., Firnau, G., Nahmias, C. Nature (1983)
- DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Hemmings, H.C., Greengard, P., Tung, H.Y., Cohen, P. Nature (1984)
- Maturational changes in cerebral function in infants determined by 18FDG positron emission tomography. Chugani, H.T., Phelps, M.E. Science (1986)
- Impaired locomotion and dopamine signaling in retinoid receptor mutant mice. Krezel, W., Ghyselinck, N., Samad, T.A., Dupé, V., Kastner, P., Borrelli, E., Chambon, P. Science (1998)
- Reduced leucine-enkephalin--like immunoreactive substance in hamster basal ganglia after long-term ethanol exposure. Blum, K., Briggs, A.H., Elston, S.F., DeLallo, L., Sheridan, P.J., Sar, M. Science (1982)
- Conversion of cerebral cortex into basal ganglia in Emx2(-/-) Pax6(Sey/Sey) double-mutant mice. Muzio, L., DiBenedetto, B., Stoykova, A., Boncinelli, E., Gruss, P., Mallamaci, A. Nat. Neurosci. (2002)
- Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3. Zeng, W.Q., Al-Yamani, E., Acierno, J.S., Slaugenhaupt, S., Gillis, T., MacDonald, M.E., Ozand, P.T., Gusella, J.F. Am. J. Hum. Genet. (2005)
- A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebellar ataxia [corrected]. van Swieten, J.C., Brusse, E., de Graaf, B.M., Krieger, E., van de Graaf, R., de Koning, I., Maat-Kievit, A., Leegwater, P., Dooijes, D., Oostra, B.A., Heutink, P. Am. J. Hum. Genet. (2003)
- Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. Testa, C.M., Standaert, D.G., Young, A.B., Penney, J.B. J. Neurosci. (1994)
- Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Farde, L., Nordström, A.L., Wiesel, F.A., Pauli, S., Halldin, C., Sedvall, G. Arch. Gen. Psychiatry (1992)
- Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. Kalivas, P.W., Duffy, P. J. Neurosci. (1993)
- Patterns of metabolic activity in the treatment of schizophrenia. Brodie, J.D., Christman, D.R., Corona, J.F., Fowler, J.S., Gomez-Mont, F., Jaeger, J., Micheels, P.A., Rotrosen, J., Russell, J.A., Volkow, N.D. Ann. Neurol. (1984)
- The pathophysiology of primary dystonia. Berardelli, A., Rothwell, J.C., Hallett, M., Thompson, P.D., Manfredi, M., Marsden, C.D. Brain (1998)
- Dopamine antagonist haloperidol decreases substance P, substance K, and preprotachykinin mRNAs in rat striatonigral neurons. Bannon, M.J., Lee, J.M., Giraud, P., Young, A., Affolter, H.U., Bonner, T.I. J. Biol. Chem. (1986)